v3.25.2
Recapitalization (Tables)
12 Months Ended
Dec. 31, 2024
Recapitalization [Abstract]  
Schedule of Consolidated Statement of Changes in Stockholders’ Deficit

The following table reconciles the elements of the Business Combination to the consolidated statement of changes in stockholders’ deficit for the period ended December 31, 2023:

 

Cash-trust and cash, net of redemptions  $241,329 
Less: transaction expenses paid   (241,329)
Net proceeds from the Business Combination   
 
Less: recognition of SPAC closing balance sheet   (762,710)
Reverse recapitalization, net  $(762,710)
Schedule of Number of Shares of Common Stock issued immediately following the consummation of the Business Combination

The number of shares of Common Stock issued immediately following the consummation of the Business Combination were:

 

EFHAC Class A common stock, outstanding prior to the Business Combination   11,500,000 
Less: Redemption of EFHAC Class A common stock   (11,477,525)
Class A common stock of EFHAC   22,475 
EFHAC public rights shares outstanding   1,437,500 
EFHAC founder shares outstanding   2,875,000 
EFHAC private shares outstanding   257,500 
EFHAC private rights shares outstanding   32,187 
EFHAC shares issued to EF Hutton (underwriter) (1)   750,000 
Business Combination shares   5,375,662 
ECD Shares   26,500,000 
Common Stock immediately after the Business Combination   31,874,662 
(1) Excludes 25,000 shares granted to Ben Piggott which were issued in January 2024, and recorded as a share issuance liability in other payable on the consolidated balance sheet at December 31, 2023.
Schedule of Number of ECD Shares

The number of ECD shares was determined as follows:

 

   ECD Shares   ECD
Shares after
conversion
ratio
 
Class A Common Stock (before Defender SPV shares)   100    24,000,000